prograf 1mg tvrdá tobolka
astellas pharma s.r.o., praha array - 16808 monohydrÁt takrolimu - tvrdá tobolka - 1mg - takrolimus
prograf 5mg tvrdá tobolka
astellas pharma s.r.o., praha array - 16808 monohydrÁt takrolimu - tvrdá tobolka - 5mg - takrolimus
prograf 5mg/ml koncentrát pro infuzní roztok
astellas pharma s.r.o., praha array - 12314 takrolimus - koncentrát pro infuzní roztok - 5mg/ml - takrolimus
nebivolol sandoz 5mg tableta
sandoz s.r.o., praha array - 12056 nebivolol-hydrochlorid - tableta - 5mg - nebivolol
amodip 1,25 mg Žvýkací tableta
ceva santé animale - amlodipin - Žvýkací tableta - deriváty dihydropyridinu - kočky
nebilet 5mg tableta
berlin-chemie ag, berlín array - 12056 nebivolol-hydrochlorid - tableta - 5mg - nebivolol
nebivolol aurovitas 5mg tableta
aurovitas, spol. s r.o., praha array - 12056 nebivolol-hydrochlorid - tableta - 5mg - nebivolol
nolibeta 5mg tableta
krka, d.d., novo mesto, novo mesto array - 12056 nebivolol-hydrochlorid - tableta - 5mg - nebivolol
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
dailiport 0,5mg tvrdá tobolka s prodlouženým uvolňováním
sandoz s.r.o., praha array - 16808 monohydrÁt takrolimu - tvrdá tobolka s prodlouženým uvolňováním - 0,5mg - takrolimus